Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.

@article{BrmondGignac2010EfficacyAS,
  title={Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.},
  author={Dominique Br{\'e}mond-Gignac and Patricia Mariani-Kurkdjian and Ariel Beresniak and Lamia El Fekih and Yasmin Rusi Bhagat and Pascale Pouliquen and Laurent Delval and Pablo L. Goldschmidt and Edouard Bingen and Isabelle Cochereau},
  journal={The Pediatric infectious disease journal},
  year={2010},
  volume={29 3},
  pages={
          222-6
        }
}
BACKGROUND Purulent bacterial conjunctivitis affects all ages with high frequency in newborns and children. In a subset of 150 children included in a large study having enrolled 1043 patients, our aim was to analyze in children, the efficacy and safety of azithromycin 1.5% eye-drops in the treatment of this disease. METHODS This multicenter, randomized, investigator-masked, parallel-group study, included 150 children and adolescents to study safety and compare azithromycin 1.5% eye drops… CONTINUE READING
BETA

Figures and Topics from this paper.

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Azithromycin 1.5% Ophthalmic Solution

VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Bacterial conjunctivitis

JH Krachmer, MJ Mannis, EJ Holland
  • 2005